Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology.
Journal Information
Full Title: Mol Neurodegener
Abbreviation: Mol Neurodegener
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Molecular Biology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"bulk rna sequencing data are available in ncbi's gene expression omnibus with the accession number gse212618."
"Declarations Ethics approval and consent to participateOur mice were housed in a temperature-controlled environment with a 12-h light–dark cycle and free access to food and water. All animal procedures were approved by the Mayo Clinic Institutional Animal Care and Use Committee (IACUC) and in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. Consent for publicationAll authors have given their consent for publication. Competing interestsGB consults for SciNeuro and Vida Ventures, had consulted for AbbVie, E-Scape, and Eisai, and serves as a Co-Editor-in-Chief for Molecular Neurodegeneration. All other authors declare no competing interests. Competing interests GB consults for SciNeuro and Vida Ventures, had consulted for AbbVie, E-Scape, and Eisai, and serves as a Co-Editor-in-Chief for Molecular Neurodegeneration. All other authors declare no competing interests."
"This work was supported by NIH grants R01AG066395 (to G.B. and N.Z.), RF1AG056130, R37AG027924, and RF1AG046205 (to G.B)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025